Tang J, Webber R J, Chang D, Chang J K, Kiang J, Wei E T
Regul Pept. 1984 Sep;9(1-2):53-9. doi: 10.1016/0167-0115(84)90007-7.
Mammalian atria contain peptides that have depressor and natriuretic activities. Four peptides, atriopeptin I to III (AP I to III) and alpha-human atrial natriuretic factor (alpha-hANP), were synthesized and assayed in the urethane-anesthetized rat for cardiovascular changes and natriuretic activities. All four peptides produced depressor responses and natriuresis. The relative activities were: alpha-hANP = AP III greater than AP II greater than AP I. The disappearance of iodinated AP III from plasma was rapid, with an estimated half-life of 2.5 min. Atriopeptin III was degraded by tissue homogenates, the relative activities being: kidney greater than liver greater than lung greater than plasma greater than heart. The HPLC profile of AP III suggested that smaller peptide fragments were formed after incubation with kidney homogenates. The degradation of AP III was inhibited by bestatin, an aminopeptidase inhibitor, and SQ 20881, a carboxypeptidase inhibitor.
哺乳动物的心房含有具有降压和利钠活性的肽。合成了四种肽,即心房肽I至III(AP I至III)和α-人心房利钠因子(α-hANP),并在氨基甲酸乙酯麻醉的大鼠中检测其对心血管变化和利钠活性的影响。所有这四种肽都产生了降压反应和利钠作用。相对活性为:α-hANP = AP III>AP II>AP I。碘化AP III从血浆中消失很快,估计半衰期为2.5分钟。心房肽III被组织匀浆降解,相对活性为:肾脏>肝脏>肺>血浆>心脏。AP III的高效液相色谱图表明,与肾脏匀浆孵育后会形成较小的肽片段。AP III的降解受到氨肽酶抑制剂贝司他汀和羧肽酶抑制剂SQ 20881的抑制。